Eckert & Ziegler SE (ETR:EUZ)
15.47
+0.05 (0.32%)
At close: Dec 5, 2025
Eckert & Ziegler SE Revenue
Eckert & Ziegler SE had revenue of 75.31M EUR in the quarter ending September 30, 2025, with 7.42% growth. This brings the company's revenue in the last twelve months to 304.47M, up 9.63% year-over-year. In the year 2024, Eckert & Ziegler SE had annual revenue of 295.85M with 20.22% growth.
Revenue (ttm)
304.47M
Revenue Growth
+9.63%
P/S Ratio
3.18
Revenue / Employee
273.80K
Employees
1,085
Market Cap
968.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 295.85M | 49.76M | 20.22% |
| Dec 31, 2023 | 246.09M | 23.86M | 10.74% |
| Dec 31, 2022 | 222.23M | 41.79M | 23.16% |
| Dec 31, 2021 | 180.44M | 4.30M | 2.44% |
| Dec 31, 2020 | 176.14M | -2.35M | -1.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.27B |
| Siemens Healthineers AG | 23.38B |
| Bayer Aktiengesellschaft | 45.87B |
| Fresenius SE & Co. KGaA | 22.45B |
| Sartorius Aktiengesellschaft | 3.52B |
| Fresenius Medical Care AG | 19.64B |
| Carl Zeiss Meditec AG | 2.18B |
| Fielmann Group AG | 2.42B |
Eckert & Ziegler SE News
- 1 day ago - EQS-News: Reorganization of the Eckert & Ziegler Executive Board - Wallstreet:Online
- 2 days ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 3 months ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 3 months ago - EQS-News: Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47% - Wallstreet:Online
- 4 months ago - Eckert & Ziegler Earnings Surge in Early 2025 - Wallstreet:Online
- 4 months ago - EQS-News: Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025 - Wallstreet:Online
- 4 months ago - EQS-News: Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025 - Wallstreet:Online
- 4 months ago - EQS-News: Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101 - Wallstreet:Online